HALO
Halozyme Therapeutics Inc. Healthcare - Biotechnology Investor Relations →
Halozyme Therapeutics Inc. (HALO) closed at $63.43 as of 2026-03-20, trading 25.0% above its 200-week moving average of $50.74. The stock is currently moving closer to the line, down from 25.7% last week. The 14-week RSI sits at 51, indicating neutral momentum.
Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.07 ratio) is neutral — neither side is clearly dominating.
Over the past 1100 weeks of data, HALO has crossed below its 200-week moving average 34 times. On average, these episodes lasted 8 weeks. Historically, investors who bought HALO at the start of these episodes saw an average one-year return of +59.6%.
With a market cap of $7.5 billion, HALO is a mid-cap stock. The company generates a free cash flow yield of 2.5%. Return on equity stands at 153.6%, indicating strong profitability. The stock trades at 153.2x book value.
The company has been aggressively buying back shares, reducing its share count by 12.9% over the past three years.
Over the past 21.2 years, a hypothetical investment of $100 in HALO would have grown to $3447, compared to $795 for the S&P 500. That represents an annualized return of 18.2% vs 10.3% for the index — confirming HALO as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 14.9% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: HALO vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After HALO Crosses Below the Line?
Across 34 historical episodes, buying HALO when it crossed below its 200-week moving average produced an average return of +57.7% after 12 months (median +47.0%), compared to +18.5% for the S&P 500 over the same periods. 91% of those episodes were profitable after one year. After 24 months, the average return was +76.4% vs +31.7% for the index.
Each line shows $100 invested at the moment HALO crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
HALO has crossed below its 200-week MA 34 times with an average 1-year return of +59.6% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Feb 2005 | Feb 2006 | 52 | 40.7% | +60.9% | +3545.4% |
| Jun 2006 | Jun 2006 | 1 | 0.8% | +307.6% | +2576.4% |
| Jul 2006 | Aug 2006 | 3 | 3.9% | +262.5% | +2634.1% |
| Oct 2008 | Dec 2008 | 10 | 39.2% | +58.1% | +1275.9% |
| Feb 2009 | Mar 2009 | 5 | 14.0% | +11.4% | +1143.7% |
| Nov 2009 | Mar 2010 | 14 | 12.9% | +23.3% | +1003.1% |
| May 2010 | Jun 2010 | 1 | 0.6% | -6.8% | +861.1% |
| Jun 2010 | Jul 2010 | 3 | 2.9% | +5.4% | +852.4% |
| Aug 2010 | Aug 2010 | 3 | 1.6% | -5.8% | +836.9% |
| Jan 2011 | Jan 2011 | 1 | 4.4% | +56.6% | +849.6% |
| Feb 2011 | Mar 2011 | 6 | 8.0% | +71.5% | +827.3% |
| Apr 2011 | Jun 2011 | 11 | 8.4% | +75.3% | +886.5% |
| Aug 2011 | Oct 2011 | 11 | 7.1% | -25.0% | +931.4% |
| Jul 2012 | Sep 2012 | 7 | 35.8% | +52.9% | +1275.9% |
| Oct 2012 | Jan 2013 | 15 | 33.8% | +61.0% | +834.2% |
| Jan 2013 | May 2013 | 15 | 29.7% | +139.8% | +871.4% |
| May 2013 | Jun 2013 | 4 | 15.8% | +11.9% | +798.4% |
| Jul 2013 | Aug 2013 | 3 | 8.3% | +31.6% | +799.7% |
| Apr 2014 | Jun 2014 | 8 | 13.6% | +108.0% | +754.9% |
| Oct 2014 | Oct 2014 | 1 | 1.7% | +70.9% | +654.2% |
| Nov 2014 | Nov 2014 | 2 | 0.9% | +80.4% | +642.7% |
| Dec 2014 | Dec 2014 | 1 | 7.3% | +92.9% | +693.9% |
| Jan 2016 | Apr 2016 | 13 | 31.7% | +12.8% | +528.0% |
| Apr 2016 | Sep 2016 | 20 | 24.7% | +32.1% | +501.2% |
| Oct 2016 | Nov 2016 | 4 | 26.9% | +73.7% | +530.5% |
| Nov 2016 | Jan 2017 | 9 | 16.1% | +62.3% | +457.9% |
| May 2017 | May 2017 | 1 | 0.1% | +48.3% | +411.1% |
| Aug 2017 | Aug 2017 | 3 | 6.2% | +42.8% | +433.0% |
| Dec 2018 | Jan 2019 | 3 | 7.0% | +30.9% | +356.7% |
| Mar 2023 | Mar 2023 | 2 | 4.8% | +23.5% | +91.7% |
| Apr 2023 | Jul 2023 | 11 | 12.4% | +12.8% | +85.1% |
| Oct 2023 | Nov 2023 | 6 | 12.2% | +58.8% | +70.2% |
| Dec 2023 | Feb 2024 | 9 | 14.3% | +26.4% | +70.7% |
| Apr 2024 | May 2024 | 4 | 4.3% | +56.0% | +64.3% |
| Average | 8 | — | +59.6% | — |
Frequently Asked Questions
Is HALO below its 200-week moving average?
No. Halozyme Therapeutics Inc. (HALO) is currently 25.0% above its 200-week moving average of $50.74. It would need to fall to $50.74 to cross below the line.
What is HALO's 200-week moving average price?
Halozyme Therapeutics Inc.'s 200-week moving average is $50.74 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when HALO drops below its 200-week moving average?
HALO has crossed below its 200-week moving average 34 times in our data. On average, buying at that moment produced a one-year return of +59.6%. These dips have historically been decent entry points. These episodes lasted 8 weeks on average.
Is HALO a good value right now?
Here's what our data says about HALO as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 51. Free cash flow yield is 2.5%. Return on equity is 153.6%. Price-to-book is 153.2x. This is not a buy or sell recommendation — always do your own research.
How does HALO compare to the S&P 500?
Over the past 21.2 years, $100 invested in HALO would have grown to $3447, compared to $795 for the S&P 500. That's 18.2% annualized vs 10.3% for the index. HALO has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20